Aleor Derma Karakhadi unit clears USFDA inspection Medical Dialogues Bureau9 Jan 2020 1:33 PM ISTMumbai: Drugmaker Alembic Pharma recently informed the bourses that its Joint Venture, Aleor Dermaceutical has successfully completed the US drug...
Streamline tax and duty structure in Union Budget 2020-21 to ensure quality medical devices: MTaI Medical Dialogues Bureau9 Jan 2020 9:24 AM IST"High customs duties have adversely impacted the costs of medical devices and equipment in India which contradicts the government's efforts to provide...
Novartis acquires The Medicines Company, adds cholesterol-lowering therapy inclisiran Medical Dialogues Bureau9 Jan 2020 9:22 AM ISTNew Delhi: Novartis AG (Novartis) recently announced that it has completed the acquisition of The Medicines Company (the “Company”) through the...
Esteve to buy German pharma firm Riemser from Ardian Medical Dialogues Bureau9 Jan 2020 9:00 AM ISTRiemser specialises in oncology, neurology, and infectiology and had since 2012 been part of Ardian's portfolio. Ardian in 2018 unsuccessfully tried...
Arena Pharma CEO Targets Brain Diseases as Next Drug Frontier- Bloomberg Report Medical Dialogues Bureau8 Jan 2020 2:10 PM ISTArena Pharmaceuticals Inc. shares have nearly tripled since Chief Executive Amit Munshi took the helm in 2016 and now he’s setting a new course as the...
Daiichi Sankyo introduces Enhertu - breast cancer drug in US Medical Dialogues Bureau8 Jan 2020 2:08 PM ISTTokyo and Basking Ridge, NJ – Daiichi Sankyo announced that ENHERTU® (fam-trastuzumab deruxtecan-nxki), a HER2 directed antibody-drug conjugate, is...
Keytruda plus chemotherapy results in statistically significant improvement in PFS compared to chemotherapy alone Medical Dialogues Bureau8 Jan 2020 2:05 PM ISTNJ- Merck has announced that the Phase 3 KEYNOTE-604 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy met...
Slayback Pharma raises USD 50 million in Series B funding from Everstone Group Medical Dialogues Bureau7 Jan 2020 3:26 PM ISTIn addition to the investment, Everstone Managing Directors Arjun Oberoi and Puncham Mukim will join Slayback Pharma's Board of Directors. Everstone...
Glenmark gets USFDA nod for Deferasirox tablets to treat high levels of iron Farhat Nasim7 Jan 2020 11:55 AM IST"Glenmark Pharmaceuticals Inc, USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (US FDA) for...
AstraZeneca Lokelma gets Chinese approval for treating hyperkalaemia Medical Dialogues Bureau7 Jan 2020 9:30 AM ISTNew Delhi: AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in China for the treatment of adult patients with hyperkalaemia...
Merck Keytruda, chemotherapy combination shows mixed results in phase 3 trial for lung cancer Medical Dialogues Bureau7 Jan 2020 9:15 AM ISTWhile the blockbuster drug showed improvement in overall survival for patients treated with Keytruda in combination with chemotherapy, it did not meet...
Drug developers including AstraZeneca, GSK take fresh aim at guided-missile cancer drugs: Report Farhat Nasim7 Jan 2020 9:00 AM ISTThese antibody-drug conjugates, or ADCs, from companies including AztraZeneca and GlaxoSmithKline, are described by researchers as "guided missiles"...
